SCHEMBL7739007

SCHEMBL7739007

CCCCC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1-c1cccc(OC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.51
FLT1 P17948 1/20 0.47
FLT4 P35916 1/20 0.47
HCAR2 Q8TDS4 1/20 0.45
HPGD P15428 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
USP2 O75604 1/20 0.44
TSHR P16473 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KMT2A Q03164 2/20 0.43
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
HSP90AA1 P07900 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ADORA1 P30542 2/20 0.42
ADORA3 P0DMS8 1/20 0.42
HDAC1 Q13547 4/20 0.41
HDAC2 Q92769 4/20 0.41
HDAC8 Q9BY41 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7739022 0.90 KDR (0.54) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744790 0.89 HPN (0.43) KDRSMN1; SMN2KMT2AMTNR1AMTNR1B
SCHEMBL7744192 0.88 KDR (0.51) KDRFLT1FLT4HCAR2HPGD
SCHEMBL7739015 0.86 KDR (0.68) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7739010 0.86 KDR (0.47) KDRFLT1FLT4HCAR2HPGD
SCHEMBL7744659 0.85 KDR (0.50) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7981663 0.85 KDR (0.50) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744041 0.85 HPGD (0.46) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7738993 0.84 KDR (0.55) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744651 0.84 HPGD (0.51) KDRFLT1FLT4HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed